DSO Acquisition Due Diligence: The Operational Checklist PE Sponsors Miss

Financial due diligence in dental platform acquisitions has become sophisticated. Recast EBITDA, normalized collections, payer mix analysis, provider concentration risk — most PE sponsors and their advisors cover these competently. The deals that destroy value post-close rarely fail because of financial due diligence gaps. They fail because of operational due diligence gaps.

Operational due diligence in dental is harder than financial due diligence. The numbers are on paper. The operations are in 30, 50, or 100 locations — in the scheduling system, in the credentialing queue, in the supply room, in the call center, in the clinical protocol variability that no one has measured. Finding the operational gaps before close is what separates a value creation story from a post-close remediation story.

At Viturtal Consulting we have conducted operational assessments across dental platforms ranging from 30 locations to hundreds of locations. The gaps that consistently destroy value — and that consistently appear in the diligence process — fall into seven categories. This checklist covers each one.

Why Operational Due Diligence Gets Shortchanged

The typical dental platform acquisition process allocates significant time and resources to financial, legal, and environmental due diligence. Operational due diligence is often compressed into a handful of management interviews and a review of process documentation.

The problem with this approach is that process documentation and process execution are not the same thing. A DSO can have beautifully documented RCM workflows, credentialing protocols, and supply chain procedures — and execute none of them consistently at the location level. The documentation tells you what the organization aspires to. The operational assessment tells you what is actually happening.

The consequence of shortchanging operational due diligence is predictable: the 100-day plan assumes operational baseline capabilities that don't exist, value creation timelines slip, and what looked like a 6x EBITDA acquisition at close becomes a 7x acquisition after remediation costs are accounted for.

The seven categories below represent the areas where operational gaps most consistently emerge — and where the difference between a thorough and a superficial diligence process is measured in millions of dollars of post-close value.

1. Revenue Cycle Management — The Most Consistently Underestimated Gap

Revenue cycle performance is the single most important operational variable in dental platform value creation — and the area where diligence most frequently produces a false sense of security.

What the financial diligence shows: Collections as a percentage of adjusted production, days in AR, payer mix breakdown, net collection rate. These metrics give a high-level view of RCM health but miss the operational detail that determines whether RCM performance is sustainable and scalable.

What operational diligence needs to find:

• Insurance AR aging by payer — not just overall AR aging. A practice can have acceptable overall AR metrics while carrying a significant concentration of aged AR with specific payers that require systematic remediation.
• Denial rate by payer and denial reason — the most important leading indicator of RCM process health. A denial rate above 8% signals systematic process failures in eligibility verification, coding, or documentation that will compound with scale.
• Clean claims rate — the percentage of claims submitted correctly on the first pass. A clean claims rate below 90% means more than 10% of claims require rework, which creates cost and cash flow drag that accelerates with volume.
• Patient AR over 180 days as a percentage of total patient AR. Anything above 30% signals collection process failures that require immediate remediation. The recoverable value from aged patient AR is real but requires a structured process that most platforms don't have in place at acquisition.
• Credentialing days — the average number of days from provider hire to active insurance credentialing. Every day a provider is not credentialed is a day of insurance revenue permanently foregone. An average credentialing time above 60 days represents a systematic revenue leak that compounds with every new hire and every new location.
• Fee schedule benchmarking — contracted rates against FairHealth 70th percentile by payer and geography. Rates that lag market benchmarks by 15% or more represent a negotiation opportunity that should be quantified and included in the value creation plan with a realistic timeline.

The diligence deliverable: A payer-by-payer RCM scorecard with denial rates, AR aging, clean claims rates, and fee schedule positioning. Not a summary — a location-by-location breakdown that identifies outliers and patterns.

2. Credentialing Infrastructure — A Revenue Leak That Accelerates With Scale

Credentialing deserves its own category because it is consistently treated as an administrative function in diligence when it is actually a revenue function that scales non-linearly with platform growth.

What to look for in diligence:

• Current average credentialing days — measured from provider hire date to first insurance payment received, not to credentialing application submission. The difference between those two measurements is often 30-60 additional days that the operational team doesn't count because the application was submitted.
• Credentialing backlog — the number of providers currently in the credentialing queue and the aging of that backlog. A platform with 50 providers in a credentialing backlog averaging 90 days has a quantifiable revenue impact that belongs in the financial model.
• Credentialing staff capacity and process — whether credentialing is managed in-house or through a delegated third-party vendor, what the SLA structure looks like, and whether the current model scales with the platform's growth plan. A platform planning to add 20 locations per year needs a credentialing infrastructure designed for that throughput, not for its current size.
• Re-credentialing cycle management — every provider credential requires renewal, typically every two years. A platform with 200 providers has 100 re-credentialing events per year that need to be tracked, initiated proactively, and completed without lapsing. Lapsed credentials create the same revenue problem as initial credentialing delays — insurance revenue stops while the credential is inactive.

The diligence deliverable: A credentialing audit covering current days to credential, active backlog, re-credentialing calendar for the next 24 months, and a vendor assessment if third-party credentialing is in use.

3. Supply Chain Maturity — Visible at the Location Level, Invisible in the Financials

Supply chain costs as a percentage of collections are reported in the financial diligence. Supply chain process maturity — the factor that determines whether those costs are sustainable and improvable — is almost never assessed in diligence.

What to look for in diligence:

• Supply expense as a percentage of collections by location — not just consolidated. Consolidated supply costs of 12% of collections can mask location-level variance from 8% to 22%, which indicates no effective cost governance at the location level.
• Vendor concentration and contract status — how many primary supply vendors the platform uses, whether purchasing is centralized or location-directed, and whether existing vendor agreements have volume-based pricing tiers that reflect the platform's actual purchasing power.
• Formulary compliance — whether locations are purchasing from the approved formulary or making independent purchasing decisions. Non-formulary purchasing is one of the most common drivers of supply cost variance in multi-location platforms and is essentially invisible without location-level purchasing data.
• Inventory management practices — whether locations maintain any inventory tracking, what expiration write-off rates look like, and whether there is any centralized visibility into inventory levels across the platform. Platforms without inventory management systems routinely carry 30-60 days of excess inventory at the location level, tying up cash and generating expiration losses.
• GPO participation and leverage — whether the platform is participating in a dental GPO, which GPO, and whether the contracted pricing reflects the platform's actual volume. Many platforms are GPO participants on paper but have not renegotiated pricing to reflect their current scale.

The diligence deliverable: A supply chain maturity assessment covering vendor concentration, formulary compliance rate, supply cost variance by location, and GPO contract terms versus current volume.

4. Workforce and Labor Model — Key Person Risk Beyond the Selling Dentist

Financial diligence addresses provider concentration risk — whether the selling dentist is the primary producer. Operational diligence needs to address the broader workforce risk that financial diligence consistently misses.

What to look for in diligence:

• RCM staff concentration risk — whether the revenue cycle function is managed by one or two key individuals whose departure would create immediate operational disruption. This is one of the most common and most dangerous forms of key person risk in dental platforms, and it is rarely identified in financial diligence.
• Clinical staff turnover by location — annual turnover rates at the location level. Locations with turnover above 35% are experiencing a patient experience problem that will manifest in recall rates, NPS scores, and eventually production trends. Aggregate turnover metrics hide location-level crises.
• Associate dentist compensation structure — whether associates are compensated on a production basis, a salary basis, or a hybrid model, and how those structures compare to market. Below-market associate compensation creates turnover risk that can materially affect production forecasts in the value creation model.
• Employment classification compliance — whether clinical staff are appropriately classified as employees versus independent contractors. In many states, 1099 classification of associate dentists is a compliance violation that creates both regulatory exposure and workforce instability. This is a financial diligence item as well, but the operational implications — what happens to production if classification is corrected — need to be modeled.
• Change readiness assessment — a qualitative evaluation of the management team's capacity and appetite for the operational changes the value creation plan requires. An operationally sophisticated management team accelerates value creation. A team that has operated autonomously for years and is resistant to standardization absorbs value creation resources without producing proportional results.

The diligence deliverable: A workforce risk assessment covering RCM key person exposure, location-level turnover data, associate compensation benchmarking, and a management team change readiness evaluation.

5. Technology and Systems — The Hidden Integration Cost

Technology assessments in dental diligence typically inventory the practice management systems in use and identify whether consolidation to a single platform is needed. The operational questions that actually determine integration cost and timeline are almost never addressed.

What to look for in diligence:

• Practice management system fragmentation — not just how many systems are in use, but how deeply embedded each system is in location workflows and what the realistic migration timeline and cost looks like for each. A platform with 8 locations on Dentrix, 12 on Eaglesoft, and 5 on a legacy system has a technology consolidation project that will consume 18-24 months of management attention and material capital — neither of which typically appears in the value creation model at the right scale.
• Data quality and reporting infrastructure — whether the platform has centralized reporting across locations, what KPIs are tracked at the executive level, and whether the data infrastructure can support the performance management systems the value creation plan requires. Platforms without centralized reporting cannot manage performance at scale — and building that infrastructure takes longer and costs more than sponsors typically model.
• Imaging technology — whether locations have digital radiography and intraoral cameras, or whether analog systems are in use. Analog radiography is a capital expenditure requirement that buyers typically identify in diligence but frequently underestimate in total replacement cost when applied across a multi-location platform.
• Cybersecurity posture — HIPAA-compliant data handling, access controls, breach history, and cyber insurance coverage. Healthcare data breaches are expensive and disruptive. A platform with inadequate cybersecurity posture is carrying a contingent liability that should be quantified and addressed in the diligence process.

The diligence deliverable: A technology inventory with migration cost estimates, data infrastructure assessment, capital expenditure requirements for imaging modernization, and a cybersecurity posture review.

6. Compliance — The Diligence Item Most Likely to Generate Post-Close Surprises

Financial diligence addresses tax compliance. Legal diligence addresses licensing and litigation. Operational diligence needs to address clinical billing compliance — the area where post-close surprises are most expensive.

What to look for in diligence:

• Billing practice consistency — whether billing practices at the location level are consistent with the platform's documented protocols and with payer contract requirements. Location-level billing inconsistencies that are not identified in diligence become the platform's liability post-close. A HIPAA audit conducted as part of diligence is not optional for platforms above 20 locations — it is the minimum standard.
• OSHA compliance — safety manual currency, bloodborne pathogen training documentation, hazard communication logs, and exposure control plans. These are administrative requirements that are consistently undermanaged at growing platforms and consistently flagged in regulatory audits.
• Associate dentist classification — as noted in the workforce section, but worth reiterating in the compliance context. The regulatory risk associated with misclassified 1099 associates extends beyond the employment relationship to include payroll tax liability, benefits obligations, and in some states dental board regulatory exposure.
• State DSO ownership structure compliance — whether the platform's corporate structure complies with each state's specific DSO ownership rules. These rules vary significantly by state, have been subject to regulatory evolution in several markets, and create material compliance risk when platforms expand into new states without adequate legal review.

The diligence deliverable: A compliance audit covering billing practice review, HIPAA documentation assessment, OSHA compliance status, associate classification review, and corporate structure analysis by state.

7. Patient Experience and Retention — The Leading Indicator Financial Diligence Misses

Financial diligence looks backward — at historical collections, production, and profitability. Operational diligence should look forward — at the leading indicators that predict whether historical performance will sustain post-close.

What to look for in diligence:

• Hygiene reappointment rate by location — the percentage of patients who schedule their next hygiene appointment before leaving the current one. A reappointment rate below 80% signals patient relationship fragility that will manifest in declining recall volume within 12-18 months. This is one of the most reliable leading indicators of patient retention available and is almost never included in financial diligence packages.
• New patient volume trends — trailing 12 months of new patient counts by location, not consolidated. Consolidated new patient volume can appear stable while individual locations experience significant new patient decline masked by growth at other locations.
• No-show and cancellation rates — particularly for new patients. High new patient no-show rates indicate a scheduling and confirmation process problem that is costing the platform production on every appointment day. A new patient no-show rate above 15% is a material operational gap.
• Patient satisfaction scores — Net Promoter Score or equivalent by location, with trend data. Declining NPS at the location level is a leading indicator of provider quality issues, patient experience failures, or competitive pressure that will affect production within 12-24 months.
• Treatment plan conversion rate — the percentage of presented treatment that patients accept and schedule. Industry benchmark is 50-60%. Platforms below 40% have a patient communication and financial presentation process problem that is suppressing revenue on every clinical encounter.

The diligence deliverable: A patient experience assessment covering hygiene reappointment rates, new patient volume trends, no-show rates, NPS data, and treatment plan conversion rates by location.

Building the Operational Due Diligence into the Value Creation Plan

The purpose of operational due diligence is not just to identify risks — it is to quantify them accurately enough to build a realistic value creation plan. Each gap identified in the seven categories above has a financial implication that should be modeled explicitly:

• A credentialing backlog of 50 providers at 90 days average, at $1,500 per provider per day in insurance revenue, is a $6.75M annual revenue gap. That number belongs in the model.
• A supply cost variance of 4 percentage points between best and worst performing locations, applied to a platform with $50M in annual collections, is a $2M annual opportunity. That number belongs in the model.
• A treatment plan conversion rate of 35% versus a 55% benchmark, applied to the platform's annual volume of presented treatment, is a quantifiable revenue opportunity that should be prioritized and sequenced in the 100-day plan.

Operational due diligence that produces a risk register but not a quantified opportunity model is incomplete. The model is what allows the investment team to evaluate whether the operational gaps are priced into the acquisition multiple — and whether the value creation plan is realistic given the baseline.

Working With Viturtal Consulting on Operational Due Diligence

Viturtal Consulting provides operational due diligence support for private equity sponsors and their portfolio companies evaluating dental platform acquisitions. Our assessments are designed to deliver the seven category analyses described in this guide within the compressed timelines of an active transaction process.

We have conducted operational assessments across dental platforms ranging from 30 locations to hundreds of locations — identifying between $13M and $263M in annual operational opportunity across engagements. Our diligence work is grounded in operational execution experience, not just advisory observation.

For PE sponsors evaluating a dental platform acquisition, Viturtal Consulting offers a structured operational due diligence engagement that produces a quantified gap analysis, a location-level risk register, and a value creation roadmap ready for integration into the 100-day plan from day one post-close.

For a detailed look at our work on the revenue cycle dimension of operational due diligence, read our RCM Transformation Case Study — a real engagement where Viturtal Consulting identified $13.2M in annual revenue opportunity across five RCM workstreams for a 30+ location DSO.

For the financial framework that underpins dental platform valuation, read our complete Dental Practice Valuation Guide covering EBITDA multiples, buyer type differences, and EBITDA recasting methodology.

Contact Dr. Hendrik Lai at hendrik@viturtal.com or visit viturtal.com to schedule a consultation.